🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, randomized, phase III study. It is aim...
Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Start Date
2022-06-20
Trial ID
NCT04841811
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
A prospective, open-label, multi-center, single-arm study of Almonertinib c...
Status
Unknown
Location
The Second Afiliated Hospital of Nanchang University
Start Date
2021-07
Trial ID
NCT04944069
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-06-09
Trial ID
NCT06947811
Treatments Being Tested
This is a Prospective, open, single arm study to evaluate the efficacy and ...
Status
Unknown
Location
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Start Date
2021-06-02
Trial ID
NCT04952168
Treatments Being Tested
This is a multicenter, randomized, open label, phase III study....
Status
Enrolling By Invitation
Location
Chinese Academy of Medical Science
Start Date
2021-08-01
Trial ID
NCT04762459
Treatments Being Tested
Aumolertinib (almonertinib; HS-10296) is a novel third-generation EGFR-TKI ...
Status
Withdrawn
Location
Sun Yat-sen University Cancer Center
Start Date
2024-06-01
Trial ID
NCT06227897
Treatments Being Tested
The reason for the study is to find out if an experimental combination of a...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2020-11-19
Trial ID
NCT04646824
Treatments Being Tested
This is a prospective, multicenter, open label study to investigate the saf...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2021-04-02
Trial ID
NCT05223595
Treatments Being Tested
To assess the efficacy and safety of Almonertinib versus placebo following ...
Status
Recruiting
Location
Shandong Cancer Hospital
Start Date
2021-03-18
Trial ID
NCT04951635
Treatments Being Tested